State Street’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $375M | Buy |
4,598,952
+252,433
| +6% | +$18.2M | 0.01% | 703 |
|
|
2026
Q1 | $296M | Buy |
4,346,519
+140,393
| +3% | +$9.94M | 0.01% | 760 |
|
|
2025
Q4 | $319M | Buy |
4,206,126
+1,071,343
| +34% | +$77.9M | 0.01% | 726 |
|
|
2025
Q3 | $192M | Buy |
3,134,783
+138,329
| +5% | +$7.21M | 0.01% | 959 |
|
|
2025
Q2 | $146M | Buy |
2,996,454
+541,558
| +22% | +$25.7M | 0.01% | 1095 |
|
|
2025
Q1 | $125M | Sell |
2,454,896
-253,100
| -9% | -$12.6M | 0.01% | 1159 |
|
|
2024
Q4 | $122M | Sell |
2,707,996
-191,044
| -7% | -$8.18M | ﹤0.01% | 1228 |
|
|
2024
Q3 | $108M | Buy |
2,899,040
+149,700
| +5% | +$5.01M | ﹤0.01% | 1284 |
|
|
2024
Q2 | $84.1M | Sell |
2,749,340
-1,360,452
| -33% | -$44.1M | ﹤0.01% | 1368 |
|
|
2024
Q1 | $120M | Sell |
4,109,792
-524,163
| -11% | -$14.7M | 0.01% | 1193 |
|
|
2023
Q4 | $128M | Buy |
4,633,955
+1,465,095
| +46% | +$33.5M | 0.01% | 1137 |
|
|
2023
Q3 | $71M | Sell |
3,168,860
-1,624
| -0.1% | -$60.4K | ﹤0.01% | 1405 |
|
|
2023
Q2 | $129M | Buy |
3,170,484
+265,351
| +9% | +$13M | 0.01% | 1054 |
|
|
2023
Q1 | $141M | Sell |
2,905,133
-533,358
| -16% | -$24.4M | 0.01% | 975 |
|
|
2022
Q4 | $131M | Buy |
3,438,491
+615,259
| +22% | +$25.6M | 0.01% | 997 |
|
|
2022
Q3 | $142M | Sell |
2,823,232
-801,645
| -22% | -$39.3M | 0.01% | 897 |
|
|
2022
Q2 | $145M | Buy |
3,624,877
+440,850
| +14% | +$15.5M | 0.01% | 925 |
|
|
2022
Q1 | $119M | Buy |
3,184,027
+382,596
| +14% | +$14.7M | 0.01% | 1176 |
|
|
2021
Q4 | $112M | Buy |
2,801,431
+152,810
| +6% | +$5.85M | 0.01% | 1216 |
|
|
2021
Q3 | $98.6M | Buy |
2,648,621
+271,594
| +11% | +$11.2M | 0.01% | 1273 |
|
|
2021
Q2 | $100M | Buy |
2,377,027
+345,169
| +17% | +$14.8M | 0.01% | 1285 |
|
|
2021
Q1 | $96.2M | Sell |
2,031,858
-149,739
| -7% | -$8.89M | 0.01% | 1265 |
|
|
2020
Q4 | $133M | Sell |
2,181,597
-102,011
| -4% | -$6.01M | 0.01% | 946 |
|
|
2020
Q3 | $107M | Sell |
2,283,608
-53,175
| -2% | -$2.62M | 0.01% | 930 |
|
|
2020
Q2 | $119M | Sell |
2,336,783
-35,894
| -2% | -$1.76M | 0.01% | 864 |
|
|
2020
Q1 | $106M | Buy |
2,372,677
+33,731
| +1% | +$1.7M | 0.01% | 827 |
|
|
2019
Q4 | $112M | Buy |
2,338,946
+264,044
| +13% | +$11.2M | 0.01% | 979 |
|
|
2019
Q3 | $70.2M | Sell |
2,074,902
-238,866
| -10% | -$10.4M | 0.01% | 1215 |
|
|
2019
Q2 | $104M | Sell |
2,313,768
-187,158
| -7% | -$7.39M | 0.01% | 1007 |
|
|
2019
Q1 | $94.1M | Buy |
2,500,926
+102,612
| +4% | +$3.45M | 0.01% | 1045 |
|
|
2018
Q4 | $82.3M | Buy |
2,398,314
+122,136
| +5% | +$4.39M | 0.01% | 1021 |
|
|
2018
Q3 | $107M | Sell |
2,276,178
-240,750
| -10% | -$9.96M | 0.01% | 1029 |
|
|
2018
Q2 | $84.9M | Buy |
2,516,928
+355,522
| +16% | +$11.1M | 0.01% | 1148 |
|
|
2018
Q1 | $58.5M | Sell |
2,161,406
-562,909
| -21% | -$14.3M | 0.01% | 1325 |
|
|
2017
Q4 | $45.4M | Buy |
2,724,315
+969,129
| +55% | +$16.4M | ﹤0.01% | 1486 |
|
|
2017
Q3 | $35.1M | Buy |
1,755,186
+75,571
| +4% | +$1.48M | ﹤0.01% | 1613 |
|
|
2017
Q2 | $30.8M | Sell |
1,679,615
-217,059
| -11% | -$2.92M | ﹤0.01% | 1685 |
|
|
2017
Q1 | $18.7M | Buy |
1,896,674
+1,302,278
| +219% | +$15.8M | ﹤0.01% | 1995 |
|
|
2016
Q4 | $6.48M | Sell |
594,396
-64,950
| -10% | -$681K | ﹤0.01% | 2543 |
|
|
2016
Q3 | $9.24M | Buy |
659,346
+76,998
| +13% | +$626K | ﹤0.01% | 2225 |
|
|
2016
Q2 | $4.09M | Sell |
582,348
-68,287
| -10% | -$501K | ﹤0.01% | 2710 |
|
|
2016
Q1 | $4.19M | Sell |
650,635
-871,274
| -57% | -$15.1M | ﹤0.01% | 2645 |
|
|
2015
Q4 | $49.3M | Buy |
1,521,909
+359,057
| +31% | +$10.6M | 0.01% | 1189 |
|
|
2015
Q3 | $31M | Buy |
1,162,852
+183,554
| +19% | +$7.85M | ﹤0.01% | 1445 |
|
|
2015
Q2 | $47.1M | Buy |
979,298
+285,814
| +41% | +$16.7M | 0.01% | 1308 |
|
|
2015
Q1 | $42.2M | Sell |
693,484
-2,413
| -0.3% | -$147K | ﹤0.01% | 1344 |
|
|
2014
Q4 | $36M | Sell |
695,897
-125,917
| -15% | -$5.54M | ﹤0.01% | 1396 |
|
|
2014
Q3 | $36.2M | Sell |
821,814
-24,024
| -3% | -$752K | ﹤0.01% | 1348 |
|
|
2014
Q2 | $22.1M | Buy |
845,838
+152,382
| +22% | +$3.26M | ﹤0.01% | 1748 |
|
|
2014
Q1 | $18.1M | Buy |
693,456
+582,142
| +523% | +$15.6M | ﹤0.01% | 1858 |
|
|
2013
Q4 | $1.89M | Buy |
111,314
+24,187
| +28% | +$425K | ﹤0.01% | 3093 |
|
|
2013
Q3 | $1.87M | Buy |
+87,127
| New | +$1.51M | ﹤0.01% | 3075 |
|
Other funds holding PTCT
RI
JT
HRCM
State Street's PTCT Position: Q2 2026 in Review
State Street increased its PTC Therapeutics (PTCT) stake by 5.8% in Q2 2026, buying an estimated $18.2M and bringing the position to 4,598,952 shares worth $375M. The position accounts for 0.01% of the portfolio, ranked #703.
State Street first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- State Street held 4,598,952 shares of PTC Therapeutics worth $375M as of Q2 2026.
- State Street bought 252,433 PTC Therapeutics shares in Q2 2026, an estimated $18.2M.
- PTC Therapeutics made up 0.01% of State Street's portfolio in Q2 2026, its #703 holding.
- State Street first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.